Academic
Publications
Minimum 6-year outcomes for interstitial cystitis treated with sacral neuromodulation

Minimum 6-year outcomes for interstitial cystitis treated with sacral neuromodulation,10.1007/s00192-010-1235-9,International Urogynecology Journal,Se

Minimum 6-year outcomes for interstitial cystitis treated with sacral neuromodulation   (Citations: 2)
BibTex | RIS | RefWorks Download
Introduction and hypothesis  Interstitial cystitis is a multifaceted medical condition consisting of pelvic pain, urgency, and frequency. Can sacral neuromodulation be successfully utilized for the medium term of ≥6 years in interstitial cystitis patients for whom standard drug therapies have failed? Methods  In our observational, retrospective, case-controlled review (January 2002–March 2004), we sought to discern whether neuromodulation could be successfully implemented with acceptable morbidity rates in interstitial cystitis patients. Thirty-four female patients underwent stage 1 and 2 InterStim placements under a general anesthetic. Simple means and medians were analyzed. Results  Mean pre-op/post-op pelvic pain and urgency/frequency scores were 21.61 ± 8.6/9.22 ± 6.6 (p p < 0.01). Median age was 41 ± 14.8 years with a mean follow-up of 86 ± 9.8 months. Conclusions  With a minimum 6-year follow-up we determined that sacral neuromodulation provides adequate improvement for the symptoms of recalcitrant interstitial cystitis.
Journal: International Urogynecology Journal - INT UROGYNECOL J , vol. 22, no. 4, pp. 407-412, 2011
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
Sort by: